Dr. Abu-Gheida is the clinical director of the department of radiation oncology at Burjeel Medical City. He is also the chief medical officer of Burjeel Medical City. Dr. Abu-Gheida is also the chairman of the first Emirates Oncology Society Radiation Oncology Work group formulated in 2023. He also serves as a regional Radiological Society of North America (RSNA) committee representative for the Middle East and Africa. Dr. Abu-Gheida completed his undergraduate training where he earned a Bachelor of Science with honors degree from the American University of Beirut. Following this, Dr. Abu-Gheida completed his Medical School training at the American University of Beirut Medical Center. He continued and joined the Department of Internal Medicine at the American University of Beirut. Then did his training in the Department of Radiation Oncology at the American University of Beirut Medical Center, where he also served as the chief resident. During his Training, Dr. Abu-Gheida completed a Harvard-affiliated NIH-funded research program as well. After his residency, Dr. Ibrahim went to Cleveland Clinic / in Ohio, where he was appointed as an Advanced Clinical Radiation Oncology Fellow. Dr. Abu-Gheida went and joined the University of Texas MD Anderson Cancer Center where he sub-specialized in treating Breast, gastrointestinal, and genitourinary cancers. Dr. Abu Gheida played an instrumental role in establishing and heading the radiation oncology facility and department at Burjeel medical city. He has chaired and co-chaired multiple international oncology conferences. Dr. Ibrahim has more than 40 peer-reviewed papers in the prestigious medical journal including the American Society of Radiation Oncology official journal - the International Journal of Radiation Oncology Biology and Physics, Nature, Journal of Clinical Oncology, and several others. He is also the primary author and editor of several book chapters published in prestigious books.